Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

MSLN expression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

MSLN expression	Lung Cancer	MSLN expression	Lung Cancer	TC-210 Sensitive: C2 – Inclusion Criteria TC-210 Sensitive : C2	TC-210 Sensitive: C2 – Inclusion Criteria TC-210 Sensitive : C2
MSLN expression	Ovarian Cancer	MSLN expression	Ovarian Cancer	TC-210 Sensitive: C2 – Inclusion Criteria TC-210 Sensitive : C2	TC-210 Sensitive: C2 – Inclusion Criteria TC-210 Sensitive : C2
MSLN expression	Mesothelioma	MSLN expression	Mesothelioma	TC-210 Sensitive: C2 – Inclusion Criteria TC-210 Sensitive : C2	TC-210 Sensitive: C2 – Inclusion Criteria TC-210 Sensitive : C2
MSLN expression	Solid Tumor	MSLN expression	Solid Tumor	BAY 94-9343 Sensitive: C2 – Inclusion Criteria BAY 94-9343 Sensitive : C2	BAY 94-9343 Sensitive: C2 – Inclusion Criteria BAY 94-9343 Sensitive : C2
MSLN expression	Pancreatic Cancer	MSLN expression	Pancreatic Cancer	T-lymphocyte cell therapy Sensitive: C4 – Case Studies T-lymphocyte cell therapy Sensitive : C4	T-lymphocyte cell therapy Sensitive: C4 – Case Studies T-lymphocyte cell therapy Sensitive : C4
MSLN expression	Ovarian Cancer	MSLN expression	Ovarian Cancer	RG7600 Sensitive: C4 – Case Studies RG7600 Sensitive : C4	RG7600 Sensitive: C4 – Case Studies RG7600 Sensitive : C4
MSLN expression	Pancreatic Cancer	MSLN expression	Pancreatic Cancer	RG7600 Sensitive: C4 – Case Studies RG7600 Sensitive : C4	RG7600 Sensitive: C4 – Case Studies RG7600 Sensitive : C4
MSLN expression	Thymic Carcinoma	MSLN expression	Thymic Carcinoma	BAY 94-9343 Sensitive: D – Preclinical BAY 94-9343 Sensitive : D	BAY 94-9343 Sensitive: D – Preclinical BAY 94-9343 Sensitive : D
MSLN expression	Ovarian Cancer	MSLN expression	Ovarian Cancer	MORAb-109 Sensitive: D – Preclinical MORAb-109 Sensitive : D	MORAb-109 Sensitive: D – Preclinical MORAb-109 Sensitive : D
MSLN expression	Ovarian Cancer	MSLN expression	Ovarian Cancer	MORAb-202 Sensitive: D – Preclinical MORAb-202 Sensitive : D	MORAb-202 Sensitive: D – Preclinical MORAb-202 Sensitive : D
MSLN expression	Solid Tumor	MSLN expression	Solid Tumor	CT-95 Sensitive: D – Preclinical CT-95 Sensitive : D	CT-95 Sensitive: D – Preclinical CT-95 Sensitive : D